Literature DB >> 12842958

Interventional pharmacotherapy.

Roger Philipp1, Ever D Grech.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12842958      PMCID: PMC1126384          DOI: 10.1136/bmj.327.7405.43

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.

Authors:  A M Lincoff; R M Califf; D J Moliterno; S G Ellis; J Ducas; J H Kramer; N S Kleiman; E A Cohen; J E Booth; S K Sapp; C F Cabot; E J Topol
Journal:  N Engl J Med       Date:  1999-07-29       Impact factor: 91.245

2.  Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2000-12-16       Impact factor: 79.321

3.  Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1998-05-21       Impact factor: 91.245

4.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Authors:  Steven R Steinhubl; Peter B Berger; J Tift Mann; Edward T A Fry; Augustin DeLago; Charles Wilmer; Eric J Topol
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

5.  Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.

Authors:  Eric Boersma; Robert A Harrington; David J Moliterno; Harvey White; Pierre Théroux; Frans Van de Werf; Anneke de Torbal; Paul W Armstrong; Lars C Wallentin; Robert G Wilcox; John Simes; Robert M Califf; Eric J Topol; Maarten L Simoons
Journal:  Lancet       Date:  2002-01-19       Impact factor: 79.321

6.  Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes.

Authors: 
Journal:  N Engl J Med       Date:  1998-08-13       Impact factor: 91.245

  6 in total
  1 in total

1.  Early changes in local hemostasis activation following percutaneous coronary intervention in stable angina patients: a comparison between drug-eluting and bare metal stents.

Authors:  Ailiman Mahemuti; Nicolas Meneveau; Marie-France Seronde; Francois Schiele; Vincent Descotes-Genon; Fiona Ecarnot; Marie-Cecile Blonde; Mariette Mercier; Evelyne Racadot; Jean-Pierre Bassand
Journal:  J Thromb Thrombolysis       Date:  2008-09-03       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.